User login
BALTIMORE – The sutureless heart valve may now be a “necessity” for contemporary cardiothoracic surgeons, said an expert at the annual meeting of the American Association for Thoracic Surgery.
In an interview at the event, Niv Ad, MD, chief of cardiac surgery at Inova Heart and Vascular Institute, Falls Church, Va., discussed the results of an international trial evaluating clinical outcomes of two patient subgroups implanted with a sutureless valve prosthesis. He was enthusiastic about the trial’s results and the future promise of the sutureless valve.
The study, "Clinical Outcomes in Low and Intermediate-High Risk Groups with a Sutureless Heart Valve," will be presented at 7:30 a.m. on Wednesday.
“This study teaches us that the technology is safe,” he said. “This is really great news for surgeons, cardiologists, and patients. Complications associated with implantation of the valves were fairly low in their incidence, and the survival rates at 1 year were high.”
The study, led by Axel Haverich, MD, of Hannover Medical School in Germany, confirmed the safety and performance of the valve in both patient groups – high and low risk – regardless of the preoperative risk score. Dr. Ad said that sutureless valve technology would likely replace suture technology in all cases, although perhaps not in the near term.
Dr. Ad reported no relevant financial disclosures.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @richpizzi
BALTIMORE – The sutureless heart valve may now be a “necessity” for contemporary cardiothoracic surgeons, said an expert at the annual meeting of the American Association for Thoracic Surgery.
In an interview at the event, Niv Ad, MD, chief of cardiac surgery at Inova Heart and Vascular Institute, Falls Church, Va., discussed the results of an international trial evaluating clinical outcomes of two patient subgroups implanted with a sutureless valve prosthesis. He was enthusiastic about the trial’s results and the future promise of the sutureless valve.
The study, "Clinical Outcomes in Low and Intermediate-High Risk Groups with a Sutureless Heart Valve," will be presented at 7:30 a.m. on Wednesday.
“This study teaches us that the technology is safe,” he said. “This is really great news for surgeons, cardiologists, and patients. Complications associated with implantation of the valves were fairly low in their incidence, and the survival rates at 1 year were high.”
The study, led by Axel Haverich, MD, of Hannover Medical School in Germany, confirmed the safety and performance of the valve in both patient groups – high and low risk – regardless of the preoperative risk score. Dr. Ad said that sutureless valve technology would likely replace suture technology in all cases, although perhaps not in the near term.
Dr. Ad reported no relevant financial disclosures.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @richpizzi
BALTIMORE – The sutureless heart valve may now be a “necessity” for contemporary cardiothoracic surgeons, said an expert at the annual meeting of the American Association for Thoracic Surgery.
In an interview at the event, Niv Ad, MD, chief of cardiac surgery at Inova Heart and Vascular Institute, Falls Church, Va., discussed the results of an international trial evaluating clinical outcomes of two patient subgroups implanted with a sutureless valve prosthesis. He was enthusiastic about the trial’s results and the future promise of the sutureless valve.
The study, "Clinical Outcomes in Low and Intermediate-High Risk Groups with a Sutureless Heart Valve," will be presented at 7:30 a.m. on Wednesday.
“This study teaches us that the technology is safe,” he said. “This is really great news for surgeons, cardiologists, and patients. Complications associated with implantation of the valves were fairly low in their incidence, and the survival rates at 1 year were high.”
The study, led by Axel Haverich, MD, of Hannover Medical School in Germany, confirmed the safety and performance of the valve in both patient groups – high and low risk – regardless of the preoperative risk score. Dr. Ad said that sutureless valve technology would likely replace suture technology in all cases, although perhaps not in the near term.
Dr. Ad reported no relevant financial disclosures.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @richpizzi
AT THE AATS ANNUAL MEETING
